OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Optimizing these processes involves fine-tuning various factors, including cell line development, media composition, and bioreactor settings. A key goal is to amplify antibody titer while minimizing production financial